Ferroptosis Inducing Co(III) Polypyridine Sulfasalazine Complex for Therapeutically Enhanced Anticancer Therapy
Authors:
Open Access
- 30 October 2024
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (48) , e202412585
Abstract
Despite significant improvements in the treatment of cancerous tumors in the last decades, cancer remains one of the deadliest diseases worldwide. To overcome the shortcomings of currently applied chemotherapeutic treatments, much research efforts have been devoted towards the development of ferroptosis inducing anticancer agents. Ferroptosis is a newly described form of regulated, non‐apoptotic cell death that is associated with high potential inside the clinics. Herein, the chemical synthesis and biological evaluation of a Co(III) polypyridine sulfasalazine complex as a ferroptosis inducer is reported. Upon entering the cancerous cells, the metal complex primarily accumulated in the mitochondria, triggering the production of hydroxy radicals and lipid peroxides, ultimately causing cell death by ferroptosis. The compound demonstrated to eradicate various monolayer cancer cells as well as colon carcinoma multicellular tumor spheroids. To the best of our knowledge this study reports on the first example of a Co(III) complex that is capable of inducing ferroptosis.Keywords
Funding Information
- Verband der Chemischen Industrie (Liebig fellowship)
- Aventis Foundation (Life Sciences Bridge Award)
- Paul-Ehrlich-Gesellschaft Stiftung (Paul Ehrlich & Ludwig Darmstaedter Early Career Award 2024)
This publication has 45 references indexed in Scilit:
- A Breast Cancer Stem Active Cobalt(III)‐Cyclam Complex Containing Flufenamic Acid with Immunogenic PotentialAngewandte Chemie International Edition, 2023
- Intelligent Size‐Switchable Iron Carbide‐Based Nanocapsules with Cascade Delivery Capacity for Hyperthermia‐Enhanced Deep Tumor FerroptosisAdvanced Materials, 2023
- Evoking Ferroptosis by Synergistic Enhancement of a Cyclopentadienyl Iridium‐Betulin Immune AgonistAngewandte Chemie International Edition, 2023
- A Biodegradable Iridium(III) Coordination Polymer for Enhanced Two‐Photon Photodynamic Therapy Using an Apoptosis–Ferroptosis Hybrid PathwayAngewandte Chemie International Edition, 2022
- Ferroptosis‐Enhanced Cancer Immunity by a Ferrocene‐Appended Iridium(III) Diphosphine ComplexAngewandte Chemie International Edition, 2021
- Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell InhibitionAngewandte Chemie International Edition, 2021
- Expanding the Arsenal of PtIV Anticancer Agents: Multi‐action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional GroupAngewandte Chemie International Edition, 2019
- Recent Progress in Ferroptosis Inducers for Cancer TherapyAdvanced Materials, 2019
- Modulation of the Biological Properties of Aspirin by Formation of a Bioorganometallic DerivativeAngewandte Chemie International Edition, 2009
- Usage of the NF‐κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancerInternational Journal of Cancer, 2003